Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 529

Similar articles for PubMed (Select 15992636)

1.

In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).

Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J; ADHERE Scientific Advisory Committee and Investigators; ADHERE Study Group.

J Am Coll Cardiol. 2005 Jul 5;46(1):57-64.

2.

Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.

Arnold LM, Crouch MA, Carroll NV, Oinonen MJ.

Pharmacotherapy. 2006 Aug;26(8):1078-85.

4.

Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.

Maisel AS, Peacock WF, McMullin N, Jessie R, Fonarow GC, Wynne J, Mills RM.

J Am Coll Cardiol. 2008 Aug 12;52(7):534-40. doi: 10.1016/j.jacc.2008.05.010.

5.
7.

Increased cost effectiveness with nesiritide vs. milrinone or dobutamine in the treatment of acute decompensated heart failure.

Scroggins N, Edwards M, Delgado R 3rd.

Congest Heart Fail. 2005 Nov-Dec;11(6):311-4.

PMID:
16330906
8.

Noninvasive ventilation outcomes in 2,430 acute decompensated heart failure patients: an ADHERE Registry Analysis.

Tallman TA, Peacock WF, Emerman CL, Lopatin M, Blicker JZ, Weber J, Yancy CW; ADHERE Registry.

Acad Emerg Med. 2008 Apr;15(4):355-62. doi: 10.1111/j.1553-2712.2008.00059.x.

PMID:
18370990
9.
10.

Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure.

Chow SL, O'Barr SA, Peng J, Chew E, Pak F, Quist R, Patel P, Patterson JH, Heywood JT.

J Card Fail. 2011 Mar;17(3):181-7. doi: 10.1016/j.cardfail.2010.10.005. Epub 2010 Dec 3.

PMID:
21362524
11.

Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE.

Peacock WF 4th, Fonarow GC, Emerman CL, Mills RM, Wynne J; ADHERE Scientific Advisory Committee and Investigators; Adhere Study Group.

Cardiology. 2007;107(1):44-51. Epub 2006 May 4.

PMID:
16741357
12.

Effect of nesiritide versus milrinone in the treatment of acute decompensated heart failure.

Lewis DA, Gurram NR, Abraham WT, Akers WS.

Am J Health Syst Pharm. 2003 Aug 15;60 Suppl 4:S16-20.

PMID:
12966902
13.

Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.

Gorodeski EZ, Chu EC, Reese JR, Shishehbor MH, Hsich E, Starling RC.

Circ Heart Fail. 2009 Jul;2(4):320-4. doi: 10.1161/CIRCHEARTFAILURE.108.839076. Epub 2009 May 14.

14.

Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.

Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC; ADHERE Scientific Advisory Committee and Investigators.

J Am Coll Cardiol. 2006 Jan 3;47(1):76-84. Epub 2005 Dec 15. Erratum in: J Am Coll Cardiol. 2006 Apr 7;47(7):1502.

15.
17.

Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.

Cohen-Solal A, Logeart D, Huang B, Cai D, Nieminen MS, Mebazaa A.

J Am Coll Cardiol. 2009 Jun 23;53(25):2343-8. doi: 10.1016/j.jacc.2009.02.058.

18.

Nesiritide: a review of its use in acute decompensated heart failure.

Keating GM, Goa KL.

Drugs. 2003;63(1):47-70. Review.

PMID:
12487622
19.

Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis.

Peacock WF, Hollander JE, Diercks DB, Lopatin M, Fonarow G, Emerman CL.

Emerg Med J. 2008 Apr;25(4):205-9. doi: 10.1136/emj.2007.050419.

PMID:
18356349
20.

Characteristics and outcomes in African American patients with decompensated heart failure.

Kamath SA, Drazner MH, Wynne J, Fonarow GC, Yancy CW.

Arch Intern Med. 2008 Jun 9;168(11):1152-8. doi: 10.1001/archinte.168.11.1152.

PMID:
18541822
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk